BioNTech SE (BNTX)
NASDAQ: BNTX · Real-Time Price · USD
90.07
-1.42 (-1.55%)
At close: Jul 13, 2026, 4:00 PM EDT
91.48
+1.41 (1.56%)
After-hours: Jul 13, 2026, 7:49 PM EDT
BioNTech SE Market Cap
BioNTech SE has a market cap or net worth of $22.78 billion as of July 13, 2026. Its market cap has decreased by -12.85% in one year.
Market Cap
22.78B
Enterprise Value
7.32B
1-Year Change
-12.85%
Ranking
Category
Stock Price
$90.07
Market Cap Chart
Since October 10, 2019, BioNTech SE's market cap has increased from $2.99B to $22.78B, an increase of 660.51%. That is a compound annual growth rate of 34.99%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 13, 2026 | 22.78B | -0.50% |
| Dec 31, 2025 | 22.89B | -16.21% |
| Dec 31, 2024 | 27.32B | 8.89% |
| Dec 29, 2023 | 25.09B | -31.28% |
| Dec 30, 2022 | 36.51B | -41.37% |
| Dec 31, 2021 | 62.26B | 217.21% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 10, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 33.21B |
| Royalty Pharma | 32.49B |
| Moderna | 27.09B |
| Roivant Sciences | 25.87B |
| Insmed | 25.06B |
| Incyte | 23.32B |
| Genmab | 17.55B |
| BridgeBio Pharma | 16.84B |